---
figid: PMC5345184__kccy-16-03-1245573-g001
figlink: /pmc/articles/PMC5345184/figure/f0001/
number: F1
caption: IFN-γR partitioned diffusion at the plasma membrane. At steady-state, IFN-γR
  is dynamically diffusing within plasma membrane sphingolipid/cholesterol nanodomains
  that are necessary for receptor subunits and associated JAK kinase conformational
  changes induced by IFN-γ binding. These molecular rearrangements lead to signal
  transduction. On the contrary, excess galectins (Gal1 & Gal3) binding on IFN-γR2
  subunit caused by the gain of glycosylation mutation (T168N) or by increased extracellular
  galectin concentration, segregates IFN-γR complex in actin nanodomains, which prevents
  JAK/STAT signaling pathway activation.
pmcid: PMC5345184
papertitle: Receptor lipid nanodomain partitioning and signaling.
reftext: Christophe Lamaze, et al. Cell Cycle. 2017;16(3):237-238.
pmc_ranked_result_index: '66828'
pathway_score: 0.9628549
filename: kccy-16-03-1245573-g001.jpg
figtitle: IFNGR partitioned diffusion at the plasma membrane
year: '2017'
organisms: Homo sapiens
ndex: dba7986d-ded7-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5345184__kccy-16-03-1245573-g001.html
  '@type': Dataset
  description: IFN-γR partitioned diffusion at the plasma membrane. At steady-state,
    IFN-γR is dynamically diffusing within plasma membrane sphingolipid/cholesterol
    nanodomains that are necessary for receptor subunits and associated JAK kinase
    conformational changes induced by IFN-γ binding. These molecular rearrangements
    lead to signal transduction. On the contrary, excess galectins (Gal1 & Gal3) binding
    on IFN-γR2 subunit caused by the gain of glycosylation mutation (T168N) or by
    increased extracellular galectin concentration, segregates IFN-γR complex in actin
    nanodomains, which prevents JAK/STAT signaling pathway activation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - JAK2
  - TYK2
  - JAK3
  - STAT4
  - STAT1
  - STAT3
  - JAK1
  - STAT2
  - STAT5A
  - STAT5B
  - STAT6
genes:
- word: JAK2
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK/STAT
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: JAK/STAT
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: JAK1
  symbol: JAK1
  source: hgnc_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK/STAT
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: JAK/STAT
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
chemicals: []
diseases: []
figid_alias: PMC5345184__F1
redirect_from: /figures/PMC5345184__F1
figtype: Figure
---
